HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response (Q39983886)

16 September 2017

title

HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response (English)

1 reference

16 September 2017

9

Britta Wahren

1 reference

16 September 2017

Elizaveta Starodubova

1

object named as

Elizaveta S Starodubova

1 reference

16 September 2017

10

Maria G Isaguliants

1 reference

16 September 2017

11

Vadim L Karpov

1 reference

16 September 2017

7

Oleg Latyshev

1 reference

16 September 2017

5

Natalia V Petrakova

1 reference

16 September 2017

8

Vera Tunitskaya

1 reference

16 September 2017

Andreas Boberg

2

1 reference

16 September 2017

Marina Litvina

3

1 reference

16 September 2017

Alexey Morozov

4

1 reference

16 September 2017

Andrey Timofeev

6

1 reference

16 September 2017

language of work or name

English

0 references

publication date

15 April 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

40

1 reference

16 September 2017

page(s)

5170-5176

1 reference

HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Mechanisms of protein degradation: an odyssey with ODC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Combined virus-like particle-based polyepitope DNA/protein HIV-1 vaccine design, immunogenicity and toxicity studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Do DNA vaccines induce autoimmune disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

The N terminus of antizyme promotes degradation of heterologous proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

PEST sequences and regulation by proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Proteasome inhibitors: valuable new tools for cell biologists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Attenuation of green fluorescent protein half-life in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Plasmid-encoded GM-CSF induces priming of the F4(K88)-specific serum IgA response by FaeG DNA vaccination in pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

The Role of Mucosal Immunity in Prevention of HIV Transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

T cells undergo rapid ON/OFF but not ON/OFF/ON cycling of cytokine production in response to antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Intranasal immunization with HIV reverse transcriptase: effect of dose in the induction of helper T cell type 1 and 2 immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Targeting plasmid-encoded proteins to the antigen presentation pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

Early and late cytotoxic T lymphocyte responses in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

inferred from DOI database lookup

7 January 2021

based on heuristic

DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.070

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.03.070

1 reference

release_76xqcjf76faz3kg6ukoyldnf3m

16 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/76xqcjf76faz3kg6ukoyldnf3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference